Biocracked
Visual approach: Macro science. Palette: Warm.

Extreme close-up of a sliced mouse liver tissue sample on a glass microscope slide, shot from a shallow overhead angle with a macro lens. The pale, creamy-yellow fat droplets mottle the deep reddish-brown tissue, so the fatty infiltration looks like glistening honey-colored bubbles of varying size. Warm amber backlight shines through the translucent edges, producing copper highlights and soft golden glows on the glass. The background falls into a blurred, burnt-orange haze. A thin, sharp line of electric green fluorescent stain traces one cluster of droplets as a subtle accent. The mood is tense and investigative, and the textures look wet, real and microscopic, with no text or labels.
Longevity

Popular Longevity Supplement AKG Caused Fatty Liver in Mice

Dr. Synapse · · 5 min read

What if one of the most talked-about longevity supplements, a molecule famous for extending healthspan in aging mice, had a hidden downside in the liver? A new study in Research suggests exactly that. Long-term alpha-ketoglutarate (AKG) intake caused fatty liver in healthy mice. The way it did so is a surprising chain of molecular events that few people taking the supplement have probably heard about.

This is a mouse study, and it is not a verdict on human safety. Even so, it asks an uncomfortable question about a supplement widely taken by healthy people.

Why AKG Became a Longevity Darling

Alpha-ketoglutarate is a central intermediate in the tricarboxylic acid (TCA) cycle, the metabolic engine that helps cells turn nutrients into energy. It also acts as a cofactor for enzymes involved in epigenetic regulation. In supplement form, often as calcium AKG (Ca-AKG), it has been marketed for anti-aging and performance benefits.

Much of the enthusiasm comes from earlier mouse work in which Ca-AKG was linked to improved healthspan and a reduction in frailty. Other reports have described antidiabetic and anti-obesity effects, mostly under pathological conditions such as diet-induced metabolic disease. In those settings AKG looked helpful.

The new study, from a team at Huazhong University of Science and Technology and collaborators in Wuhan, asked a question that has received much less attention. What happens when healthy animals take AKG for a long time? That is the situation of many real-world supplement users, who are often not sick at all.

The Finding: Fat Piling Up in the Liver

The researchers gave healthy mice AKG for an extended period, either mixed into their food or dissolved in their drinking water. Both routes produced the same result: markedly elevated hepatic triglyceride levels and steatosis, the medical term for fatty liver.

The cause was not simply more fat being made. AKG suppressed the activity of adipose triglyceride lipase (Atgl), the key enzyme that breaks down stored triglycerides. With that fat-burning machinery dampened, fat accumulated in liver cells.

The Molecular Chain of Events

The more interesting part of the paper is how AKG achieves this. The authors trace a multi-step pathway.

Step 1: Epigenetic change at Pck1. AKG reduced H3K4me3, a histone mark associated with active gene promoters, at the promoter of Pck1. Despite what one might expect from a lower activating mark, Pck1 transcription went up. Pck1 encodes phosphoenolpyruvate carboxykinase 1, a key metabolic enzyme.

Step 2: More lactate. Higher Pck1 activity promoted lactate production in the liver.

Step 3: Lactylation of Cidec. Lactate is not just a metabolic byproduct. It can be attached to proteins as a chemical modification called lactylation. Here it modified Cidec (cell death-inducing DNA fragmentation factor 45-like effector C), a lipid-droplet protein that inhibits Atgl.

Step 4: Protection from degradation. Normally the E3 ligase TRIM21 tags Cidec with ubiquitin, marking it for destruction. Lactylation interfered with this ubiquitination, so Cidec became more stable and accumulated.

Step 5: Atgl is restrained. With more Cidec around, Atgl activity was inhibited, triglyceride breakdown slowed, and fat built up.

The authors call this a "lactylation-ubiquitination crosstalk," in which one protein modification blocks another to alter protein stability and, ultimately, lipid metabolism.

Proof the Pathway Matters

The study did not rely on correlation alone. Hepatocyte-specific knockdown of either Cidec or Pck1 markedly reduced AKG-induced steatosis. Remove a key link in the chain and the fatty liver largely failed to develop, which is strong evidence that this pathway drives the effect.

How to Reconcile This With Earlier Lifespan Results

The obvious puzzle is how a compound that appeared to improve healthspan in mice can also promote fatty liver. There are several plausible ways to think about it, though the paper itself does not settle the question.

  • Context matters. Benefits reported in disease models or aging cohorts do not necessarily carry over to young, healthy animals, and the reverse is also true.
  • Dose and duration. Chronic, continuous exposure may tip metabolic pathways in ways that short or intermittent use does not.
  • Tissue-specific trade-offs. A change that is neutral or helpful in one tissue or setting can be harmful in the liver, where lipid handling is tightly controlled.

The authors conclude that even AKG, a compound with established health benefits, may pose a risk of liver injury when used chronically in healthy mice. That is a caution about chronic use in healthy animals, not a claim that the earlier findings were wrong.

What This Study Does Not Show

It is worth being clear about the limits.

  • Mice only. There are no human data here. Whether people taking AKG develop fatty liver is unknown from this work.
  • Dose translation. Doses used in rodents do not map neatly onto supplement doses in people.
  • Fatty liver is not liver failure. Steatosis is an early and often reversible state, though it can progress in some people.
  • The mechanism is the novelty. The study's main contribution is identifying the Pck1–lactate–Cidec–TRIM21–Atgl axis, which may inform future research well beyond AKG.

The authors declared no competing interests.

Practical Takeaways

Who is affected? The people most relevant to this question are healthy adults taking AKG or Ca-AKG daily for months or years in pursuit of longevity or performance. People who already have fatty liver disease, metabolic syndrome, obesity, heavy alcohol use or elevated liver enzymes have more reason to be careful, though this study did not test those groups.

What to monitor. If you take AKG long-term, consider asking your doctor about routine liver tests such as ALT and AST, and about whether a metabolic panel or liver imaging makes sense given your risk factors. Tracking these markers over time is more informative than a single reading.

Talk to your clinician. Tell your doctor about all supplements you take, particularly if you use several at once or take medications processed by the liver.

Don't panic, but stay aware. A mouse study does not mean AKG is dangerous to humans. It does mean that "natural" and "metabolite found in the body" do not equal "risk-free at chronic supplemental doses." Human trials with liver endpoints would be the logical next step.

The Bigger Picture

The longevity supplement market often moves faster than the evidence. Promising results in aged mice can turn into mass-market products long before long-term safety in healthy humans is established. This study is a reminder that metabolic intermediates are active signaling molecules, and that chronic supplementation can reshape epigenetic marks, protein modifications and lipid handling in unexpected ways.

For now, the finding is a flag, not a verdict. It points to a specific, testable mechanism and gives researchers a clear target to look for in people.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

A wide landscape editorial photograph of a minimalist laboratory-meets-wellness still life on a pale, warm-gray stone countertop, softly lit by diffused morning window light from the left. In the center foreground, a small amber glass supplement jar with a plain matte white label sits beside a scattering of fine white powder and a few loose white capsules on a ceramic dish. Next to it rests a clean, open notebook with faint hand-drawn line graphs, two diverging curves rising gently, one slightly higher than the other, drawn in muted sage-green and charcoal ink. A slim brass pen lies across the page.

In the soft-focus midground, a delicate glass beaker filled with clear liquid catches a thin streak of light, casting a gentle caustic shimmer across the stone. A sprig of dried eucalyptus and a small sliver of citrus peel add organic texture. Behind them, an out-of-focus wall of pale oat-colored tiles and a floating wooden shelf holds a few blurred ceramic vessels and a small potted fern.

The color palette is calm and editorial: warm creams, sage green, soft amber, muted terracotta accents, and touches of charcoal. Shallow depth of field with a crisp focus on the jar and notebook, creamy bokeh in the background. Subtle film-like grain, natural shadows, and generous negative space on the right third of the frame, suitable for headline overlay. The mood is thoughtful, measured, and trustworthy, like a contemporary science and wellness journal cover: modern, tactile, quietly optimistic, and grounded rather than hyped.
longevity

Calcium Alpha-Ketoglutarate Extended Female Mouse Lifespan by Up to 16.6%. Here's What That Does (and Doesn't) Mean for Humans

BY DR. SYNAPSE ·

A 2020 Cell Metabolism study found that feeding middle-aged mice a 2% calcium alpha-ketoglutarate diet extended female median lifespan by up to 16.6% and reduced frailty. The effect was smaller in the second cohort (10.5%), and male survival gains were not statistically significant. Researchers link the benefit to lower systemic inflammation and a proposed rise in IL-10. But this was a mouse-only study, and it does not establish that AKG extends human lifespan. Here is what the data show, how they differ from supplement marketing, and why CaAKG belongs on a research watchlist rather than in a proven protocol.

Approach: conceptual metaphor. Palette: bold color field.

A single ripe, glossy red tomato-colored apple sits at the center of a saturated mustard-yellow seamless backdrop, with a neat row of five identical white capsules lined up beside it on the same surface. The apple is the clear winner of the frame. One capsule has rolled slightly away, cracked open and spilling a tiny pile of pale powder. Shot at a low three-quarter angle with a shallow depth of field, so the back capsules blur softly. Lighting is a large, soft key light from the upper left, giving crisp but gentle shadows with warm yellow bounce. A thin sprig of electric green (#00e676) leaves rises from the apple stem as the only green accent. Mood: confident, playful and skeptical, a clean verdict that real food outweighs pills. No text or labels.
longevity

Zombie Cell Supplements? 27 Human Trials Say Diet Beats Pills

BY NOVA CHEN ·

Supplement labels love to promise they'll "clear zombie cells," but a new systematic review of 27 human trials and 3,811 participants suggests the evidence is thin. Calorie restriction produced the most consistent drop in senescence-linked inflammatory signals. Omega-3 was the most promising supplement, though the evidence was limited and mixed. Telomere length and the classic p16/p21 markers mostly failed to move. Here's what that means for what you eat and what you buy.

Approach: Macro science. Palette: D, bold color field.

An extreme close-up microscopy-style photograph of a single giant megakaryocyte cell, a large lumpy, lobed cell with a textured, slightly translucent surface, budding off dozens of tiny, smooth, disc-shaped platelets that drift away on fine stringy extensions. The cell and platelets are a warm pearly ivory with subtle coral-pink internal granules and a few small electric green (#00e676) fluorescent specks inside, suggesting recycling vesicles. The backdrop is a saturated, even tomato-red to deep orange color field with a soft gradient. Shot from slightly above at a three-quarter angle, with shallow depth of field so the nearest platelets are crisp and the distant ones melt into soft blur. Lighting is clean, diffuse and glowing from behind, giving gentle rim highlights. Mood: curious, precise, quietly cautionary. No text.
longevity

CoQ10 Calmed 'Old' Platelets in Aged Mice—Here's the Catch

BY NOVA CHEN ·

A new Aging Cell study reports that CoQ10 improved the function of aged megakaryocytes, the bone marrow cells that make platelets, in mice. Treated animals showed reduced platelet aggregation and activation, though platelet counts didn't change. The effect appeared to run partly through COPS3 and autophagy, the cell's recycling system. But this was mouse and cell-line research with no human data and no proof of clot prevention. Here is what it means, what it doesn't, and why people on blood thinners should talk to a doctor first.

Approach 2, lab in action, with palette D, bold color field.

Overhead-angled close shot of a gloved hand in a pale purple nitrile glove holding an open agar petri dish above a saturated mustard-yellow lab bench. Inside the dish, dozens of tiny translucent C. elegans worms trace sinuous curved tracks across a faintly glowing bacterial lawn. A small cluster of the worms shows a subtle electric green fluorescence along their bodies, suggesting neurons. Beside the dish, a microcentrifuge tube holds a pale golden-yellow DHM solution, with a pipette tip hovering nearby. Lighting is bright, crisp, directional studio-style lab light with soft short shadows. The shallow depth of field blurs the background to a smooth yellow. The mood is curious, precise and optimistic, with a slightly playful contrast between the vivid backdrop and the delicate, nearly invisible animals.
longevity

Hangover Supplement DHM Stretched Worm Lifespan by Up to 15%

BY NOVA CHEN ·

The same compound sold in hangover capsules just stretched worm lifespan by up to 15%. In a new C. elegans study, dihydromyricetin (DHM) also protected touch-receptor neurons, kept the worms moving longer, and lowered intestinal fat. The lifespan effect did not depend on the classic longevity gene daf-16, and standard antioxidant reporters were not induced, which hints at a more unusual mechanism. But this is worms only, the micromolar doses do not translate to capsule doses, and there is no human longevity data.

This page is available in